Menu
PacPremier
Magic Hour
Montecito
Loading...
You are here:  Home  >  'biosimilar'
Latest

Judge upholds Amgen’s Enbrel patents

By   /  Wednesday, July 1st, 2020  /  Biotech, Earnings, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Judge upholds Amgen’s Enbrel patents

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen seeks license for biosimilar version of oncology drug Rituxan

By   /  Thursday, December 19th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on Amgen seeks license for biosimilar version of oncology drug Rituxan

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen tackles rheumatoid arthritis with third biosimilar to get FDA OK

By   /  Friday, December 13th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, right  /  Comments Off on Amgen tackles rheumatoid arthritis with third biosimilar to get FDA OK

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets approval for arthritis drug biosimilar

By   /  Friday, December 6th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on Amgen gets approval for arthritis drug biosimilar

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen fends off biosimilar for arthritis drug Enbrel

By   /  Friday, August 16th, 2019  /  Biotech, East Ventura County, Law, right, Tri-County Public Companies  /  Comments Off on Amgen fends off biosimilar for arthritis drug Enbrel

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

FDA approves Amgen biosimilar Kanjinti

By   /  Thursday, June 13th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on FDA approves Amgen biosimilar Kanjinti

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

FDA approves biosimilar competitor to Amgen’s Enbrel

By   /  Friday, April 26th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on FDA approves biosimilar competitor to Amgen’s Enbrel

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →